feed,title,long_url,short_url
SSRN,"Safety and Cross-Reactive Immune Response Against the Omicron Variant of a Third Dose of CoronaVac, and Immune Persistence of Primary Immunization in Healthy Children and Adolescents: Interim Results from a Double-Blind, Randomised, Placebo-Controlled Phase 2 Clinical Trial",https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4099431,
